New search | Conferencedetail
Print view

2nd Next Generation Kinase Inhibitors Summit

Evvnt Promotion / evvnt
22.02.2023 - 23.02.2023  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 8:00 am to 6:00 pm
Conference themes
With strong effectiveness profiles and 20 years of FDA approval, kinase inhibitors have revolutionized oncology treatment. The success of current kinase inhibitor classes is nevertheless constrained by rising resistance and security concerns.
Scientific Society
Hanson Wade
Speakers: Erik Schaefer, Co-Founder, President, Chief Executive Officer and Chief Scientific Officer, AssayQuant Technologies Inc., Gerhard Mueller, Chief Scientific Officer, Anavo Therapeutics, Harish Dave, Chief Medical Officer, AUM Biosciences

Enquiries and Registration:
Mr. Min Ratcliffe
Health Services, Public Health
Congress fees
Free: USD 0.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)newTreeÄrztekammer für WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzCharité International AcademyAlumni Club Medizinische Universität WienCenter of Excellence